The government has launched a new pharmaceutical manufacturing policy aimed at increasing Ghana’s share of locally manufactured medicines from 30% to 60% and reducing reliance on imports.
The Cabinet-approved Ghana Pharmaceutical Manufacturing Policy was launched by the Ministry of Trade, Agribusiness and Industry in Accra on Wednesday, October 28, 2026.
Speaking at the launch, the sector minister, Elizabeth Ofosu-Adjare, said the policy was designed to address Ghana’s dependence on imported medicines, which accounts for about 70% of the country’s medicine supply.
The policy is also expected to create skilled industrial jobs and position Ghana as a major pharmaceutical manufacturing hub in West Africa.
The government’s target of increasing local production to 60% forms part of President John Dramani Mahama’s broader goal of achieving 70% self-sufficiency in pharmaceutical manufacturing.
“Medicines are not ordinary goods. A country that cannot produce its own essential medicines leaves its health, economy, and sovereignty vulnerable,” Ms Ofosu-Adjare said.
She said the policy would provide a coordinated framework for aligning investment, regulation, public procurement, skills development and regional trade to support local pharmaceutical manufacturers.
The policy is built around six key areas, including improving the quality of locally manufactured medicines to meet international standards, expanding market access through public procurement and the National Health Insurance Scheme, and providing affordable long-term financing for manufacturers.
Other priorities include expanding domestic production beyond medicine packaging to cover active pharmaceutical ingredients, excipients and vaccines, strengthening research and industrial skills, and increasing pharmaceutical exports through the African Continental Free Trade Area and the Economic Community of West African States.
The government intends to work with institutions including Development Bank Ghana, Ghana EXIM Bank and the Ghana Investment Promotion Centre to improve access to financing for pharmaceutical companies.
The policy also seeks to strengthen collaboration between universities and industry while developing the skills needed to support pharmaceutical manufacturing.
The launch brought together representatives from the Ministry of Health, Ministry of Finance, Food and Drugs Authority, National Vaccine Institute, Development Bank Ghana, the German development agency GIZ, the World Health Organization and the European Union.




